Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTCQB: ISGIF) Expands Reach with New Global Partnership

InsuraGuest goes live with Guesty, the world’s leading end-to-end short-term rental property management software Property managers who use Guesty to manage their short-term rentals: rentals which are listed on multiple platforms such as Airbnb, HomeAway, Vrbo, TripAdvisor, Agoda, and Booking.com Company’s success has hinged not only the caliber of management but even more so on […]

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Contracts Torrey Hills Capital to Boost Awareness of Its Proprietary Cancer Visualization Technology

Torrey Hills Capital is a leading investor and financial public relations firm that offers extensive expertise in investor relations, corporate communications and other market support operations The services provided to Imagin Medical will be overseen by Torrey Hills Founder and Principal Cliff Mastricola Imagin believes its proprietary imaging technology, the i/Blue Imaging System(TM), will establish […]

Hollywall Entertainment Inc. (HWAL) Is ‘One to Watch’

Hollywall Entertainment Inc. is currently working on expanding the company through the acquisition of businesses within its targeted industries Hollywall subsidiaries are already working on multiple projects, most notably its HWDC subsidiary’s focus on the smart city concept leveraging 5G technology, internet of things and other innovative technologies The global 5G market is estimated to […]

United Medical Equipment Business Solutions Network Inc. Breaks Barriers to Medication Adherence

Flaws in the U.S. health-care system revealed during COVID-19 pandemic Lack of medication adherence can lead to serious issues, including worsening of disease, possible death and increased costs United Medical offers solutions for poor patient-physician communication and inadequate medication knowledge The COVID-19 pandemic has revealed flaws in the U.S. health-care system, including flaws that require […]

HYB Holding Corp. (HYBG) Is ‘One to Watch’

HYB Holding Corp.’s subsidiary, Mediscan Inc., offers technology that can turn 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views Mediscan’s technology has multiple applications in lung, cardiac and musculoskeletal imaging and related applications A portable ultrasound scanner equipped with the Mediscan application […]

CannAssist International Corp. (CNSC) Addresses CBD Absorption Issues with Proprietary CiBiDinol Technology

CBD products in oil-based form have compromised bioavailability, according to experts CNSC’s Xceptol CBD products created with proprietary CiBiDinol technology that addresses absorption issues for superior efficacy Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Growing in popularity in a myriad of markets, cannabidiol […]

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

Ovarian cancer is a leading cause of death, causes more death than any other female reproductive system cancer POAI’s Helomics dedicated to improving clinical decision making for ovarian cancer patients Helomics has pioneered testing of drugs on patients’ own tumors to help oncologists individualize treatment options According to the American Cancer Society, an estimated 21,750 […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Credibility with HyBryte Research Publication

April 1, 2026

The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, reinforcing the importance of scientific transparency as the company advances treatments for […]

Rotate your device 90° to view site.